<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34174288</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>03</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1083-351X</ISSN><JournalIssue CitedMedium="Internet"><Volume>297</Volume><Issue>2</Issue><PubDate><Year>2021</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The Journal of biological chemistry</Title><ISOAbbreviation>J Biol Chem</ISOAbbreviation></Journal><ArticleTitle>The RNA helicase DHX36-G4R1 modulates C9orf72 GGGGCC hexanucleotide repeat-associated translation.</ArticleTitle><Pagination><StartPage>100914</StartPage><MedlinePgn>100914</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100914</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbc.2021.100914</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0021-9258(21)00714-6</ELocationID><Abstract><AbstractText>GGGGCC (G<sub>4</sub>C<sub>2</sub>) hexanucleotide repeat expansions in the endosomal trafficking gene C9orf72 are the most common genetic cause of ALS and frontotemporal dementia. Repeat-associated non-AUG (RAN) translation of this expansion through near-cognate initiation codon usage and internal ribosomal entry generates toxic proteins that accumulate in patients' brains and contribute to disease pathogenesis. The helicase protein DEAH-box helicase 36 (DHX36-G4R1) plays active roles in RNA and DNA G-quadruplex (G4) resolution in cells. As G<sub>4</sub>C<sub>2</sub> repeats are known to form G4 structures in&#xa0;vitro, we sought to determine the impact of manipulating DHX36 expression on repeat transcription and RAN translation. Using a series of luciferase reporter assays both in cells and in&#xa0;vitro, we found that DHX36 depletion suppresses RAN translation in a repeat length-dependent manner, whereas overexpression of DHX36 enhances RAN translation from G<sub>4</sub>C<sub>2</sub> reporter RNAs. Moreover, upregulation of RAN translation that is typically triggered by integrated stress response activation is prevented by loss of DHX36. These results suggest that DHX36 is active in regulating G<sub>4</sub>C<sub>2</sub> repeat translation, providing potential implications for therapeutic development in nucleotide repeat expansion disorders.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Yi-Ju</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA; Cellular and Molecular Biology Graduate Program, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sandwith</LastName><ForeName>Siara N</ForeName><Initials>SN</Initials><AffiliationInfo><Affiliation>Department of Biology, Ball State University, Muncie, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>Katelyn M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chambers</LastName><ForeName>Antonio E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Biology, Ball State University, Muncie, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krans</LastName><ForeName>Amy</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raimer</LastName><ForeName>Heather M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sharlow</LastName><ForeName>Meredith E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Biology, Ball State University, Muncie, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reisinger</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biology, Ball State University, Muncie, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richardson</LastName><ForeName>Adam E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Biology, Ball State University, Muncie, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Routh</LastName><ForeName>Eric D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smaldino</LastName><ForeName>Melissa A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Biology, Ball State University, Muncie, Indiana, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yuh-Hwa</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Genetics, University of Virginia, Charlottesville, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vaughn</LastName><ForeName>James P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Division of Cancer Biology, NanoMedica LLC, Winston-Salem, North Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todd</LastName><ForeName>Peter K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA; Department of Neurology, Ann Arbor VA Medical Center, Ann Arbor, Michigan, USA. Electronic address: petertod@med.umich.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smaldino</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>Department of Biology, Ball State University, Muncie, Indiana, USA. Electronic address: pjsmaldino@bsu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS086810</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 GM101192</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX003231</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>P50 HD104463</GrantID><Acronym>HD</Acronym><Agency>NICHD NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>I01 BX004842</GrantID><Acronym>BX</Acronym><Agency>BLRD VA</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM139787</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS099280</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007315</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R15 AG067291</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM008136</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>06</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Biol Chem</MedlineTA><NlmUniqueID>2985121R</NlmUniqueID><ISSNLinking>0021-9258</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000073885">C9orf72 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C568651">C9orf72 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C466988">DHX36 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D053487">DEAD-box RNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000073885" MajorTopicYN="N">C9orf72 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D053487" MajorTopicYN="N">DEAD-box RNA Helicases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042622" MajorTopicYN="Y">DNA Repeat Expansion</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054856" MajorTopicYN="Y">G-Quadruplexes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014176" MajorTopicYN="N">Protein Biosynthesis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020365" MajorTopicYN="N">RNA Helicases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS (Lou Gehrig's disease)</Keyword><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">DHX36&#x2013;G4R1&#x2013;RHAU</Keyword><Keyword MajorTopicYN="N">DNA helicase</Keyword><Keyword MajorTopicYN="N">G-quadruplex</Keyword><Keyword MajorTopicYN="N">RNA helicase</Keyword><Keyword MajorTopicYN="N">dipeptide repeat proteins</Keyword><Keyword MajorTopicYN="N">fragile X</Keyword><Keyword MajorTopicYN="N">repeat-associated non-AUG translation</Keyword></KeywordList><CoiStatement>Conflict of interest P. K. T. served as a paid consultant for Denali Therapeutics, holds a joint patent with Ionis Therapeutics, and receives publishing royalties from UpToDate. None of these are directly relevant to his role on this article, and none of these organizations have any role in the conception, preparation, or editing of this article. All other authors declare that they have no conflicts of interest with the contents of this article.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>4</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>6</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>6</Month><Day>26</Day><Hour>20</Hour><Minute>10</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34174288</ArticleId><ArticleId IdType="pmc">PMC8326427</ArticleId><ArticleId IdType="doi">10.1016/j.jbc.2021.100914</ArticleId><ArticleId IdType="pii">S0021-9258(21)00714-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-S&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A. A&#xa0;hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72:257&#x2013;268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72:245&#x2013;256.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Mossevelde S., van der Zee J., Cruts M., Van Broeckhoven C. Relationship between C9orf72 repeat size and clinical phenotype. Curr. Opin. Genet. Dev. 2017;44:117&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">28319737</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrne S., Heverin M., Elamin M., Walsh C., Hardiman O. Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2014;15:148&#x2013;150.</Citation><ArticleIdList><ArticleId IdType="pubmed">24053774</ArticleId></ArticleIdList></Reference><Reference><Citation>Umoh M.E., Fournier C., Li Y., Polak M., Shaw L., Landers J.E., Hu W., Gearing M., Glass J.D. Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population. Neurology. 2016;87:1024&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5027809</ArticleId><ArticleId IdType="pubmed">27488601</ArticleId></ArticleIdList></Reference><Reference><Citation>Haeusler A.R., Donnelly C.J., Periz G., Simko E.A., Shaw P.G., Kim M.S., Maragakis N.J., Troncoso J.C., Pandey A., Sattler R., Rothstein J.D., Wang J. C9orf72 nucleotide repeat structures initiate molecular cascades of disease. Nature. 2014;507:195&#x2013;200.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4046618</ArticleId><ArticleId IdType="pubmed">24598541</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly C.J., Zhang P.W., Pham J.T., Haeusler A.R., Heusler A.R., Mistry N.A., Vidensky S., Daley E.L., Poth E.M., Hoover B., Fines D.M., Maragakis N., Tienari P.J., Petrucelli L., Traynor B.J. RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013;80:415&#x2013;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Conlon E.G., Lu L., Sharma A., Yamazaki T., Tang T., Shneider N.A., Manley J.L. The C9ORF72 GGGGCC expansion forms RNA G-quadruplex inclusions and sequesters hnRNP H to disrupt splicing in ALS brains. Elife. 2016;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5050020</ArticleId><ArticleId IdType="pubmed">27623008</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P., Mizielinska S., Nicoll A.J., Zloh M., Fisher E.M.C., Parkinson G., Isaacs A.M. C9orf72 hexanucleotide repeat associated with amyotrophic lateral sclerosis and frontotemporal dementia forms RNA G-quadruplexes. Sci. Rep. 2012;2:1016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3527825</ArticleId><ArticleId IdType="pubmed">23264878</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Z., Zhang Y., Gendron T.F., Bauer P.O., Chew J., Yang W.-Y., Fostvedt E., Jansen-West K., Belzil V.V., Desaro P., Johnston A., Overstreet K., Oh S.-Y., Todd P.K., Berry J.D. Discovery of a biomarker and lead small molecules to target r(GGGGCC)-associated defects in c9FTD/ALS. Neuron. 2014;83:1043&#x2013;1050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4232217</ArticleId><ArticleId IdType="pubmed">25132468</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Liu C., Geng Y., Zhu G. Topology of a G-quadruplex DNA formed by C9orf72 hexanucleotide repeats associated with ALS and FTD. Sci. Rep. 2015;5:16673.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4643247</ArticleId><ArticleId IdType="pubmed">26564809</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamiri B., Reddy K., Macgregor R.B., Pearson C.E. TMPyP4 porphyrin distorts RNA G-quadruplex structures of the disease-associated r(GGGGCC)n repeat of the C9orf72 gene and blocks interaction of RNAbinding proteins. J.&#xa0;Biol. Chem. 2014;289:4653&#x2013;4659.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3931028</ArticleId><ArticleId IdType="pubmed">24371143</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone R., Balendra R., Moens T.G., Preza E., Wilson K.M., Heslegrave A., Woodling N.S., Niccoli T., Gilbert-Jaramillo J., Abdelkarim S., Clayton E.L., Clarke M., Konrad M.T., Nicoll A.J., Mitchell J.S. G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in&#xa0;vitro and in&#xa0;vivo. EMBO Mol. Med. 2018;10:22&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5760849</ArticleId><ArticleId IdType="pubmed">29113975</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendoza O., Bourdoncle A., Boul&#xe9; J.-B., Brosh R.M., Mergny J.-L. G-quadruplexes and helicases. Nucleic Acids Res. 2016;44:1989&#x2013;2006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4797304</ArticleId><ArticleId IdType="pubmed">26883636</ArticleId></ArticleIdList></Reference><Reference><Citation>Maizels N. G4-associated human diseases. EMBO Rep. 2015;16:910&#x2013;922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4552485</ArticleId><ArticleId IdType="pubmed">26150098</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes D., Lipps H.J. G-quadruplexes and their regulatory roles in biology. Nucleic Acids Res. 2015;43:8627&#x2013;8637.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4605312</ArticleId><ArticleId IdType="pubmed">26350216</ArticleId></ArticleIdList></Reference><Reference><Citation>Biffi G., Tannahill D., McCafferty J., Balasubramanian S. Quantitative visualization of DNA G-quadruplex structures in human cells. Nat. Chem. 2013;5:182&#x2013;186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3622242</ArticleId><ArticleId IdType="pubmed">23422559</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson A., Wu Y., Huang Y.C., Chavez E.A., Platt J., Johnson F.B., Brosh R.M., Sen D., Lansdorp P.M. Detection of G-quadruplex DNA in mammalian cells. Nucleic Acids Res. 2014;42:860&#x2013;869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3902944</ArticleId><ArticleId IdType="pubmed">24163102</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;nsel-Hertsch R., Beraldi D., Lensing S.V., Marsico G., Zyner K., Parry A., Di Antonio M., Pike J., Kimura H., Narita M., Tannahill D., Balasubramanian S. G-quadruplex structures mark human regulatory chromatin. Nat. Genet. 2016;48:1267&#x2013;1272.</Citation><ArticleIdList><ArticleId IdType="pubmed">27618450</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers V.S., Marsico G., Boutell J.M., Di Antonio M., Smith G.P., Balasubramanian S. High-throughput sequencing of DNA G-quadruplex structures in the human genome. Nat. Biotechnol. 2015;33:877&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pubmed">26192317</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedrat A., Lacroix L., Mergny J.-L. Re-evaluation of G-quadruplex propensity with G4Hunter. Nucleic Acids Res. 2016;44:1746&#x2013;1759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4770238</ArticleId><ArticleId IdType="pubmed">26792894</ArticleId></ArticleIdList></Reference><Reference><Citation>Huppert J.L., Balasubramanian S. Prevalence of quadruplexes in the human genome. Nucleic Acids Res. 2005;33:2908&#x2013;2916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1140081</ArticleId><ArticleId IdType="pubmed">15914667</ArticleId></ArticleIdList></Reference><Reference><Citation>Huppert J.L., Balasubramanian S. G-quadruplexes in promoters throughout the human genome. Nucleic Acids Res. 2007;35:406&#x2013;413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1802602</ArticleId><ArticleId IdType="pubmed">17169996</ArticleId></ArticleIdList></Reference><Reference><Citation>Maltby C.J., Schofield J.P.R., Houghton S.D., O&#x2019;Kelly I., Vargas-Caballero M., Deinhardt K., Coldwell M.J. A&#xa0;5&#x2019; UTR GGN repeat controls localisation and translation of a potassium leak channel mRNA through G-quadruplex formation. Nucleic Acids Res. 2020;48:9822&#x2013;9839.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7515701</ArticleId><ArticleId IdType="pubmed">32870280</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y., Lin S., Staats K.A., Li Y., Chang W.H., Hung S.T., Hendricks E., Linares G.R., Wang Y., Son E.Y., Wen X., Kisler K., Wilkinson B., Menendez L., Sugawara T. Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat. Med. 2018;24:313&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi K.Y., Mori E., Nizami Z.F., Lin Y., Kato M., Xiang S., Wu L.C., Ding M., Yu Y., Gall J.G., McKnight S.L. Toxic PRn poly-dipeptides encoded by the C9orf72 repeat expansion block nuclear import and export. Proc. Natl. Acad. Sci. U. S. A. 2017;114:E1111&#x2013;E1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5320981</ArticleId><ArticleId IdType="pubmed">28069952</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor J.P. A&#xa0;PR plug for the nuclear pore in amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. U. S. A. 2017;114:1445&#x2013;1447.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5321024</ArticleId><ArticleId IdType="pubmed">28159889</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez C.M., Todd P.K. New pathologic mechanisms in nucleotide repeat expansion disorders. Neurobiol. Dis. 2019;130:104515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6689435</ArticleId><ArticleId IdType="pubmed">31229686</ArticleId></ArticleIdList></Reference><Reference><Citation>Green K.M., Glineburg M.R., Kearse M.G., Flores B.N., Linsalata A.E., Fedak S.J., Goldstrohm A.C., Barmada S.J., Todd P.K. RAN translation at C9orf72-associated repeat expansions is selectively enhanced by the integrated stress response. Nat. Commun. 2017;8:2005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5722904</ArticleId><ArticleId IdType="pubmed">29222490</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W., Wang S., Mestre A.A., Fu C., Makarem A., Xian F., Hayes L.R., Lopez-Gonzalez R., Drenner K., Jiang J., Cleveland D.W., Sun S. C9ORF72 GGGGCC repeat-associated non-AUG translation is upregulated by stress through eIF2&#x3b1; phosphorylation. Nat. Commun. 2018;9:51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5754368</ArticleId><ArticleId IdType="pubmed">29302060</ArticleId></ArticleIdList></Reference><Reference><Citation>Tabet R., Schaeffer L., Freyermuth F., Jambeau M., Workman M., Lee C.Z., Lin C.C., Jiang J., Jansen-West K., Abou-Hamdan H., D&#xe9;saubry L., Gendron T., Petrucelli L., Martin F., Lagier-Tourenne C. CUG initiation and frameshifting enable production of dipeptide repeat proteins from ALS/FTD C9ORF72 transcripts. Nat. Commun. 2018;9:152.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5764992</ArticleId><ArticleId IdType="pubmed">29323119</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonobe Y., Ghadge G., Masaki K., Sendoel A., Fuchs E., Roos R.P. Translation of dipeptide repeat proteins from the C9ORF72 expanded repeat is associated with cellular stress. Neurobiol. Dis. 2018;116:155&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6331062</ArticleId><ArticleId IdType="pubmed">29792928</ArticleId></ArticleIdList></Reference><Reference><Citation>Linsalata A.E., He F., Malik A.M., Glineburg M.R., Green K.M., Natla S., Flores B.N., Krans A., Archbold H.C., Fedak S.J., Barmada S.J., Todd P.K. DDX3X and specific initiation factors modulate FMR1 repeat-associated non-AUG-initiated translation. EMBO Rep. 2019;20</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6726903</ArticleId><ArticleId IdType="pubmed">31347257</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng W., Wang S., Zhang Z., Morgens D.W., Hayes L.R., Lee S., Portz B., Xie Y., Nguyen B.V., Haney M.S., Yan S., Dong D., Coyne A.N., Yang J., Xian F. CRISPR-Cas9 screens identify the RNA helicase DDX3X as a repressor of C9ORF72 (GGGGCC)n repeat-associated non-AUG translation. Neuron. 2019;104:885&#x2013;898.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6895427</ArticleId><ArticleId IdType="pubmed">31587919</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada S.B., Gendron T.F., Niccoli T., Genuth N.R., Grosely R., Shi Y., Glaria I., Kramer N.J., Nakayama L., Fang S., Dinger T.J.I., Thoeng A., Rocha G., Barna M., Puglisi J.D. RPS25 is required for efficient RAN translation of C9orf72 and other neurodegenerative disease-associated nucleotide repeats. Nat. Neurosci. 2019;22:1383&#x2013;1388.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6713615</ArticleId><ArticleId IdType="pubmed">31358992</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman L.D., Prudencio M., Srinivasan A.R., Rifai O.M., Lee V.M.-Y., Petrucelli L., Bonini N.M. eIF4B and eIF4H mediate GR production from expanded G4C2 in a Drosophila model for C9orf72-associated ALS. Acta Neuropathol. Commun. 2019;7:62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6485101</ArticleId><ArticleId IdType="pubmed">31023341</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T., McAvoy K., Russell K., Wen X., Pang Y., Morris B., Pasinelli P., Trotti D., Haeusler A. Repeat-associated non-AUG translation in C9orf72-ALS/FTD is driven by neuronal excitation and stress. EMBO Mol. Med. 2019;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6365928</ArticleId><ArticleId IdType="pubmed">30617154</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T., Guo S., Bardhi O., Ryskamp D.A., Li J., Khoramian Tusi S., Engelbrecht A., Klippel K., Chakrabarty P., Nguyen L., Golde T.E., Sonenberg N., Ranum L.P.W. Metformin inhibits RAN translation through PKR pathway and mitigates disease in C9orf72 ALS/FTD mice. Proc. Natl. Acad. Sci. U. S. A. 2020;117:18591&#x2013;18599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7414156</ArticleId><ArticleId IdType="pubmed">32690681</ArticleId></ArticleIdList></Reference><Reference><Citation>Schult P., Paeschke K. The DEAH helicase DHX36 and its role in G-quadruplex-dependent processes. Biol. Chem. 2020;402:581&#x2013;591.</Citation><ArticleIdList><ArticleId IdType="pubmed">33021960</ArticleId></ArticleIdList></Reference><Reference><Citation>Creacy S.D., Routh E.D., Iwamoto F., Nagamine Y., Akman S.A., Vaughn J.P. G4 resolvase 1 binds both DNA and RNA tetramolecular quadruplex with high affinity and is the major source of tetramolecular quadruplex G4-DNA and G4-RNA resolving activity in HeLa cell lysates. J.&#xa0;Biol. Chem. 2008;283:34626&#x2013;34634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2596407</ArticleId><ArticleId IdType="pubmed">18842585</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughn J.P., Creacy S.D., Routh E.D., Joyner-Butt C., Jenkins G.S., Pauli S., Nagamine Y., Akman S.A. The DEXH protein product of the DHX36 gene is the major source of tetramolecular quadruplex G4-DNA resolving activity in HeLa cell lysates&#x2217;. J.&#xa0;Biol. Chem. 2005;280:38117&#x2013;38120.</Citation><ArticleIdList><ArticleId IdType="pubmed">16150737</ArticleId></ArticleIdList></Reference><Reference><Citation>Booy E.P., McRae E.K., Howard R., Deo S.R., Ariyo E.O., Dzananovic E., Meier M., Stetefeld J., McKenna S.A. RNA helicase associated with AU-rich element (RHAU/DHX36) interacts with the 3&#x2032;-tail of the long non-coding RNA BC200 (BCYRN1) J.&#xa0;Biol. Chem. 2016;291:5355&#x2013;5372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4777866</ArticleId><ArticleId IdType="pubmed">26740632</ArticleId></ArticleIdList></Reference><Reference><Citation>Booy E.P., Howard R., Marushchak O., Ariyo E.O., Meier M., Novakowski S.K., Deo S.R., Dzananovic E., Stetefeld J., McKenna S.A. The RNA helicase RHAU (DHX36) suppresses expression of the transcription factor PITX1. Nucleic Acids Res. 2014;42:3346&#x2013;3361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3950718</ArticleId><ArticleId IdType="pubmed">24369427</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang W., Smaldino P.J., Zhang Q., Miller L.D., Cao P., Stadelman K., Wan M., Giri B., Lei M., Nagamine Y., Vaughn J.P., Akman S.A., Sui G. Yin Yang 1 contains G-quadruplex structures in its promoter and 5&#x2032;-UTR and its expression is modulated by G4 resolvase 1. Nucleic Acids Res. 2012;40:1033&#x2013;1049.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3273823</ArticleId><ArticleId IdType="pubmed">21993297</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie J., Jiang M., Zhang X., Tang H., Jin H., Huang X., Yuan B., Zhang C., Lai J.C., Nagamine Y., Pan D., Wang W., Yang Z. Post-transcriptional regulation of Nkx2-5 by RHAU in heart development. Cell Rep. 2015;13:723&#x2013;732.</Citation><ArticleIdList><ArticleId IdType="pubmed">26489465</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H.-N., Lee J.-H., Bae S.-C., Ryoo H.-M., Kim H.-H., Ha H., Lee Z.H. Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcription. J.&#xa0;Bone Miner. Res. 2011;26:2161&#x2013;2173.</Citation><ArticleIdList><ArticleId IdType="pubmed">21590736</ArticleId></ArticleIdList></Reference><Reference><Citation>Smaldino P.J., Routh E.D., Kim J.H., Giri B., Creacy S.D., Hantgan R.R., Akman S.A., Vaughn J.P. Mutational dissection of telomeric DNA binding requirements of G4 resolvase 1 shows that G4-structure and certain 3&#x2032;-tail sequences are sufficient for tight and complete binding. PLoS One. 2015;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4501837</ArticleId><ArticleId IdType="pubmed">26172836</ArticleId></ArticleIdList></Reference><Reference><Citation>Sexton A.N., Collins K. The 5&#x2032; guanosine tracts of human telomerase RNA are recognized by the G-quadruplex binding domain of the RNA helicase DHX36 and function to increase RNA accumulation. Mol. Cell. Biol. 2011;31:736&#x2013;743.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3028649</ArticleId><ArticleId IdType="pubmed">21149580</ArticleId></ArticleIdList></Reference><Reference><Citation>McRae E.K.S., Booy E.P., Moya-Torres A., Ezzati P., Stetefeld J., McKenna S.A. Human DDX21 binds and unwinds RNA guanine quadruplexes. Nucleic Acids Res. 2017;45:6656&#x2013;6668.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5499804</ArticleId><ArticleId IdType="pubmed">28472472</ArticleId></ArticleIdList></Reference><Reference><Citation>Booy E.P., McRae E.K.S., McKenna S.A. Biochemical characterization of G4 quadruplex telomerase RNA unwinding by the RNA helicase RHAU. Methods Mol. Biol. 2015;1259:125&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">25579584</ArticleId></ArticleIdList></Reference><Reference><Citation>Booy E.P., Meier M., Okun N., Novakowski S.K., Xiong S., Stetefeld J., McKenna S.A. The RNA helicase RHAU (DHX36) unwinds a G4-quadruplex in human telomerase RNA and promotes the formation of the P1 helix template boundary. Nucleic Acids Res. 2012;40:4110&#x2013;4124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3351167</ArticleId><ArticleId IdType="pubmed">22238380</ArticleId></ArticleIdList></Reference><Reference><Citation>Giri B., Smaldino P.J., Thys R.G., Creacy S.D., Routh E.D., Hantgan R.R., Lattmann S., Nagamine Y., Akman S.A., Vaughn J.P. G4 resolvase 1 tightly binds and unwinds unimolecular G4-DNA. Nucleic Acids Res. 2011;39:7161&#x2013;7178.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3167620</ArticleId><ArticleId IdType="pubmed">21586581</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauer M., Juranek S.A., Marks J., De Magis A., Kazemier H.G., Hilbig D., Benhalevy D., Wang X., Hafner M., Paeschke K. DHX36 prevents the accumulation of translationally inactive mRNAs with G4-structures in untranslated regions. Nat. Commun. 2019;10:2421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6547686</ArticleId><ArticleId IdType="pubmed">31160600</ArticleId></ArticleIdList></Reference><Reference><Citation>Vester K., Eravci M., Serikawa T., Sch&#xfc;tze T., Weise C., Kurreck J. RNAi-mediated knockdown of the Rhau helicase preferentially depletes proteins with a Guanine-quadruplex motif in the 5&#x2019;-UTR of their mRNA. Biochem. Biophys. Res. Commun. 2019;508:756&#x2013;761.</Citation><ArticleIdList><ArticleId IdType="pubmed">30528389</ArticleId></ArticleIdList></Reference><Reference><Citation>Murat P., Marsico G., Herdy B., Ghanbarian A., Portella G., Balasubramanian S. RNA G-quadruplexes at upstream open reading frames cause DHX36- and DHX9-dependent translation of human mRNAs. Genome Biol. 2018;19:229.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6307142</ArticleId><ArticleId IdType="pubmed">30591072</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M.C., Tippana R., Demeshkina N.A., Murat P., Balasubramanian S., Myong S., Ferr&#xe9;-D'Amar&#xe9; A.R. Structural basis of G-quadruplex unfolding by the DEAH/RHA helicase DHX36. Nature. 2018;558:465&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6261253</ArticleId><ArticleId IdType="pubmed">29899445</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwamoto F., Stadler M., Chalupn&#xed;kov&#xe1; K., Oakeley E., Nagamine Y. Transcription-dependent nucleolar cap localization and possible nuclear function of DExH RNA helicase RHAU. Exp. Cell Res. 2008;314:1378&#x2013;1391.</Citation><ArticleIdList><ArticleId IdType="pubmed">18279852</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmidt E.K., Clavarino G., Ceppi M., Pierre P. SUnSET, a nonradioactive method to monitor protein synthesis. Nat. Methods. 2009;6:275&#x2013;277.</Citation><ArticleIdList><ArticleId IdType="pubmed">19305406</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd P.K., Oh S.Y., Krans A., He F., Sellier C., Frazer M., Renoux A.J., Chen K.-C., Scaglione K.M., Basrur V., Elenitoba-Johnson K., Vonsattel J.P., Louis E.D., Sutton M.A., Taylor J.P. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron. 2013;78:440&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3831531</ArticleId><ArticleId IdType="pubmed">23602499</ArticleId></ArticleIdList></Reference><Reference><Citation>Krans A., Kearse M.G., Todd P.K. Repeat-associated non-AUG translation from antisense CCG repeats in fragile X tremor/ataxia syndrome. Ann. Neurol. 2016;80:871&#x2013;881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5177492</ArticleId><ArticleId IdType="pubmed">27761921</ArticleId></ArticleIdList></Reference><Reference><Citation>Buijsen R.A., Visser J.A., Kramer P., Severijnen E.A., Gearing M., Charlet-Berguerand N., Sherman S.L., Berman R.F., Willemsen R., Hukema R.K. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency. Hum. Reprod. 2016;31:158&#x2013;168.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4677964</ArticleId><ArticleId IdType="pubmed">26537920</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellier C., Buijsen R.A.M., He F., Natla S., Jung L., Tropel P., Gaucherot A., Jacobs H., Meziane H., Vincent A., Champy M.-F., Sorg T., Pavlovic G., Wattenhofer-Donze M., Birling M.-C. Translation of expanded CGG repeats into FMRpolyG is pathogenic and may contribute to fragile X tremor ataxia syndrome. Neuron. 2017;93:331&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5263258</ArticleId><ArticleId IdType="pubmed">28065649</ArticleId></ArticleIdList></Reference><Reference><Citation>Buijsen R.A., Sellier C., Severijnen L.-A.W., Oulad-Abdelghani M., Verhagen R.F., Berman R.F., Charlet-Berguerand N., Willemsen R., Hukema R.K. FMRpolyG-positive inclusions in CNS and non-CNS organs of a fragile X premutation carrier with fragile X-associated tremor/ataxia syndrome. Acta Neuropathol. Commun. 2014;2:162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4254384</ArticleId><ArticleId IdType="pubmed">25471011</ArticleId></ArticleIdList></Reference><Reference><Citation>Hukema R.K., Buijsen R.A., Schonewille M., Raske C., Severijnen L.A., Nieuwenhuizen-Bakker I., Verhagen R.F., van Dessel L., Maas A., Charlet-Berguerand N., De Zeeuw C.I., Hagerman P.J., Berman R.F., Willemsen R. Reversibility of neuropathology and motor deficits in an inducible mouse model for FXTAS. Hum. Mol. Genet. 2015;24:4948&#x2013;4957.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4527492</ArticleId><ArticleId IdType="pubmed">26060190</ArticleId></ArticleIdList></Reference><Reference><Citation>Usdin K., Woodford K.J. CGG repeats associated with DNA instability and chromosome fragility form structures that block DNA synthesis in&#xa0;vitro. Nucleic Acids Res. 1995;23:4202&#x2013;4209.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC307363</ArticleId><ArticleId IdType="pubmed">7479085</ArticleId></ArticleIdList></Reference><Reference><Citation>Fry M., Loeb L.A. The fragile X syndrome d(CGG)(n) nucleotide repeats form a stable tetrahelical structure. Proc. Natl. Acad. Sci. U. S. A. 1994;91:4950&#x2013;4954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC43907</ArticleId><ArticleId IdType="pubmed">8197163</ArticleId></ArticleIdList></Reference><Reference><Citation>Kettani A., Kumar A.R., Patel D.J. Solution structure of a DNA quadruplex containing the fragile X syndrome triplet repeat. J.&#xa0;Mol. Biol. 1995;254:638&#x2013;656.</Citation><ArticleIdList><ArticleId IdType="pubmed">7500339</ArticleId></ArticleIdList></Reference><Reference><Citation>Asamitsu S., Yabuki Y., Ikenoshita S., Kawakubo K., Kawasaki M., Usuki S., Nakayama Y., Adachi K., Kugoh H., Ishii K., Matsuura T., Nanba E., Sugiyama H., Fukunaga K., Shioda N. CGG repeat RNA G-quadruplexes interact with FMRpolyG to cause neuronal dysfunction in fragile X-related tremor/ataxia syndrome. Sci. Adv. 2021;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7806243</ArticleId><ArticleId IdType="pubmed">33523882</ArticleId></ArticleIdList></Reference><Reference><Citation>Kearse M.G., Green K.M., Krans A., Rodriguez C.M., Linsalata A.E., Goldstrohm A.C., Todd P.K. CGG repeat-associated non-AUG translation utilizes a cap-dependent scanning mechanism of initiation to produce toxic proteins. Mol. Cell. 2016;62:314&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4854189</ArticleId><ArticleId IdType="pubmed">27041225</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S., Krishnan G., Rushe M., Gu Y., Kankel M.W., Gao F.-B. Production of poly(GA) in C9ORF72 patient motor neurons derived from induced pluripotent stem cells. Acta Neuropathol. 2019;138:1099&#x2013;1101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6851345</ArticleId><ArticleId IdType="pubmed">31624870</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson R.J., Hellen C.U., Pestova T.V. The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 2010;11:113&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4461372</ArticleId><ArticleId IdType="pubmed">20094052</ArticleId></ArticleIdList></Reference><Reference><Citation>Walter P., Ron D. The unfolded protein response: From stress pathway to homeostatic regulation. Science. 2011;334:1081&#x2013;1086.</Citation><ArticleIdList><ArticleId IdType="pubmed">22116877</ArticleId></ArticleIdList></Reference><Reference><Citation>Young S.K., Baird T.D., Wek R.C. Translation regulation of the glutamyl-prolyl-tRNA synthetase gene EPRS through bypass of upstream open reading frames with noncanonical initiation codons. J.&#xa0;Biol. Chem. 2016;291:10824&#x2013;10835.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4865927</ArticleId><ArticleId IdType="pubmed">27002157</ArticleId></ArticleIdList></Reference><Reference><Citation>Starck S.R., Tsai J.C., Chen K., Shodiya M., Wang L., Yahiro K., Martins-Green M., Shastri N., Walter P. Translation from the 5&#x2019; untranslated region shapes the integrated stress response. Science. 2016;351</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4882168</ArticleId><ArticleId IdType="pubmed">26823435</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinnebusch A.G., Ivanov I.P., Sonenberg N. Translational control by 5&#x2032;-untranslated regions of eukaryotic mRNAs. Science. 2016;352:1413&#x2013;1416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7422601</ArticleId><ArticleId IdType="pubmed">27313038</ArticleId></ArticleIdList></Reference><Reference><Citation>Simone R., Fratta P., Neidle S., Parkinson G.N., Isaacs A.M. G-quadruplexes: Emerging roles in neurodegenerative diseases and the non-coding transcriptome. FEBS Lett. 2015;589:1653&#x2013;1668.</Citation><ArticleIdList><ArticleId IdType="pubmed">25979174</ArticleId></ArticleIdList></Reference><Reference><Citation>Schofield J.P.R., Cowan J.L., Coldwell M.J. G-quadruplexes mediate local translation in neurons. Biochem. Soc. Trans. 2015;43:338&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pubmed">26009173</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunelle J.L., Green R. In&#xa0;vitro transcription from plasmid or PCR-amplified DNA. Methods Enzymol. 2013;530:101&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">24034317</ArticleId></ArticleIdList></Reference><Reference><Citation>Zu T., Liu Y., Ba&#xf1;ez-Coronel M., Reid T., Pletnikova O., Lewis J., Miller T.M., Harms M.B., Falchook A.E., Subramony S.H., Ostrow L.W., Rothstein J.D., Troncoso J.C., Ranum L.P. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. U. S. A. 2013;110:E4968&#x2013;E4977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3870665</ArticleId><ArticleId IdType="pubmed">24248382</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Lu Y.N., Paul T., Periz G., Banco M.T., Ferr&#xe9;-D'Amar&#xe9; A.R., Rothstein J.D., Hayes L.R., Myong S., Wang J. A&#xa0;helicase unwinds hexanucleotide repeat RNA G-quadruplexes and facilitates repeat-associated non-AUG translation. J.&#xa0;Am. Chem. Soc. 2021;143:7368&#x2013;7379.</Citation><ArticleIdList><ArticleId IdType="pubmed">33855846</ArticleId></ArticleIdList></Reference><Reference><Citation>Westergard T., Jensen B.K., Wen X., Cai J., Kropf E., Iacovitti L., Pasinelli P., Trotti D. Cell-to-cell transmission of dipeptide repeat proteins linked to C9orf72-ALS/FTD. Cell Rep. 2016;17:645&#x2013;652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5078984</ArticleId><ArticleId IdType="pubmed">27732842</ArticleId></ArticleIdList></Reference><Reference><Citation>Chalupn&#xed;kov&#xe1; K., Lattmann S., Selak N., Iwamoto F., Fujiki Y., Nagamine Y. Recruitment of the RNA helicase RHAU to stress granules via a unique RNA-binding domain. J.&#xa0;Biol. Chem. 2008;283:35186&#x2013;35198.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3259895</ArticleId><ArticleId IdType="pubmed">18854321</ArticleId></ArticleIdList></Reference><Reference><Citation>Byrd A.K., Zybailov B.L., Maddukuri L., Gao J., Marecki J.C., Jaiswal M., Bell M.R., Griffin W.C., Reed M.R., Chib S., Mackintosh S.G., MacNicol A.M., Baldini G., Eoff R.L., Raney K.D. Evidence that G-quadruplex DNA accumulates in the cytoplasm and participates in stress granule assembly in response to oxidative stress. J.&#xa0;Biol. Chem. 2016;291:18041&#x2013;18057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5016190</ArticleId><ArticleId IdType="pubmed">27369081</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoo J.-S., Takahasi K., Ng C.S., Ouda R., Onomoto K., Yoneyama M., Lai J.C., Lattmann S., Nagamine Y., Matsui T., Iwabuchi K., Kato H., Fujita T. DHX36 enhances RIG-I signaling by facilitating PKR-mediated antiviral stress granule formation. PLoS Pathog. 2014;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3961341</ArticleId><ArticleId IdType="pubmed">24651521</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoneley M., Willis A.E. Cellular internal ribosome entry segments: Structures, trans-acting factors and regulation of gene expression. Oncogene. 2004;23:3200&#x2013;3207.</Citation><ArticleIdList><ArticleId IdType="pubmed">15094769</ArticleId></ArticleIdList></Reference><Reference><Citation>Komar A.A., Hatzoglou M. Cellular IRES-mediated translation: The war of ITAFs in pathophysiological states. Cell Cycle. 2011;10:229&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3048795</ArticleId><ArticleId IdType="pubmed">21220943</ArticleId></ArticleIdList></Reference><Reference><Citation>Komar A.A., Hatzoglou M. Internal ribosome entry sites in cellular mRNAs: Mystery of their existence. J.&#xa0;Biol. Chem. 2005;280:23425&#x2013;23428.</Citation><ArticleIdList><ArticleId IdType="pubmed">15749702</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>